These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31562694)

  • 21. A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X.
    Ogiwara K; Nogami K; Matsumoto N; Noguchi-Sasaki M; Hirata M; Soeda T; Shima M
    Int J Hematol; 2020 Nov; 112(5):621-630. PubMed ID: 32748217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved hemostasis in hemophilia mice by means of an engineered factor Va mutant.
    von Drygalski A; Cramer TJ; Bhat V; Griffin JH; Gale AJ; Mosnier LO
    J Thromb Haemost; 2014; 12(3):363-72. PubMed ID: 24818532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A modified thrombin generation test for investigating very low levels of factor VIII activity in hemophilia A.
    Matsumoto T; Nogami K; Ogiwara K; Shima M
    Int J Hematol; 2009 Dec; 90(5):576-582. PubMed ID: 19937483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High levels of factor VIII activity in patients with acquired hemophilia A in remission are associated with unusually low coagulation potentials.
    Shibasaki F; Takeyama M; Ogiwara K; Furukawa S; Nakajima Y; Shimonishi N; Nogami K
    Int J Hematol; 2023 May; 117(5):669-677. PubMed ID: 36607560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FVIII/VWF complex displays a greater pro-haemostatic activity than FVIII preparations devoid of VWF: Study in plasma and cell-based models.
    Ammollo CT; Semeraro F; Vitulli A; Dirienzo L; Mezzasoma AM; Semeraro N; Gresele P; Colucci M
    Haemophilia; 2020 Jul; 26(4):e151-e160. PubMed ID: 32325538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FVIII inhibitors display FV-neutralizing activity in the prothrombin time assay.
    Arsiccio A; Beavis J; Raut S; Coxon CH
    J Thromb Haemost; 2021 Aug; 19(8):1907-1913. PubMed ID: 33914406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN).
    van 't Veer C; Golden NJ; Kalafatis M; Simioni P; Bertina RM; Mann KG
    Blood; 1997 Oct; 90(8):3067-72. PubMed ID: 9376587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does activated protein C-resistant factor V contribute to thrombin generation in hemophilic plasma?
    Bos MH; Meijerman DW; van der Zwaan C; Mertens K
    J Thromb Haemost; 2005 Mar; 3(3):522-30. PubMed ID: 15748243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation potential of immobilised factor VIII in flow-dependent fibrin generation on platelet surfaces.
    Doi M; Sugimoto M; Matsui H; Matsunari Y; Shima M
    Thromb Haemost; 2013 Aug; 110(2):316-22. PubMed ID: 23636463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-dependent coagulation assays for factor VIII efficacy measurement after substitution therapy in patients with haemophilia A.
    Bassus S; Wegert W; Krause M; Escuriola-Ettinghausen C; Siegemund A; Petros S; Scholz T; Scharrer I; Kreuz W; Engelmann L; Kirchmaier CM
    Platelets; 2006 Sep; 17(6):378-84. PubMed ID: 16973498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of thrombin generation in hemophilia A plasma by coagulation factor VIII and characterization of antibody-specific inhibition.
    Doshi BS; Gangadharan B; Doering CB; Meeks SL
    PLoS One; 2012; 7(10):e48172. PubMed ID: 23144741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emicizumab-mediated haemostatic function in patients with haemophilia A is down-regulated by activated protein C through inactivation of activated factor V.
    Yada K; Nogami K; Shinozawa K; Kitazawa T; Hattori K; Amano K; Fukutake K; Shima M
    Br J Haematol; 2018 Oct; 183(2):257-266. PubMed ID: 30125997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor VIII contributes to platelet-fibrin thrombus formation via thrombin generation under low shear conditions.
    Sugita C; Yamashita A; Moriguchi-Goto S; Furukoji E; Takahashi M; Harada A; Soeda T; Kitazawa T; Hattori K; Tamura S; Asada Y
    Thromb Res; 2009 Nov; 124(5):601-7. PubMed ID: 19660789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor.
    Waters EK; Genga RM; Schwartz MC; Nelson JA; Schaub RG; Olson KA; Kurz JC; McGinness KE
    Blood; 2011 May; 117(20):5514-22. PubMed ID: 21389323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of platelet-surface-bound proteins during coagulation under flow I: TFPI.
    Miyazawa K; Fogelson AL; Leiderman K
    Biophys J; 2023 Jan; 122(1):99-113. PubMed ID: 36403087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood coagulation in hemophilia A and hemophilia C.
    Cawthern KM; van 't Veer C; Lock JB; DiLorenzo ME; Branda RF; Mann KG
    Blood; 1998 Jun; 91(12):4581-92. PubMed ID: 9616154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disulfide bond-stabilized factor VIII has prolonged factor VIIIa activity and improved potency in whole blood clotting assays.
    Radtke KP; Griffin JH; Riceberg J; Gale AJ
    J Thromb Haemost; 2007 Jan; 5(1):102-8. PubMed ID: 17059431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mild phenotype in severe hemophilia A with Arg1781His mutation is associated with enhanced binding affinity of factor VIII for factor X.
    Yada K; Nogami K; Wakabayashi H; Fay PJ; Shima M
    Thromb Haemost; 2013 Jun; 109(6):1007-15. PubMed ID: 23467620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.
    van 't Veer C; Hackeng TM; Delahaye C; Sixma JJ; Bouma BN
    Blood; 1994 Aug; 84(4):1132-42. PubMed ID: 8049429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of global haemostasis in severe haemophilia A following factor VIII infusion.
    Lewis SJ; Stephens E; Florou G; Macartney NJ; Hathaway LS; Knipping J; Collins PW
    Br J Haematol; 2007 Sep; 138(6):775-82. PubMed ID: 17672884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.